Literature DB >> 12866024

Centrosomal abnormality is common in and a potential biomarker for bladder cancer.

Feng Jiang1, Nancy P Caraway, Anita L Sabichi, Hua Z Zhang, Arnout Ruitrok, H Barton Grossman, Jun Gu, Seth P Lerner, Scott Lippman, Ruth L Katz.   

Abstract

Centrosomal abnormalities have been implicated in chromosomal segregation aberrations that result from the formation of multipolar mitotic spindles and lead to aneuploidy. Aneuploidy is a characteristic of neoplasia and underlies the development and progression of bladder cancer. Therefore, centrosomal abnormality may play a key role in urothelial tumor transformation. The purpose of our investigation was to determine whether centrosomal abnormalities are present in malignant urothelial cells, define the relationship between centrosomal abnormalities and aneuploidy and determine whether the presence of centrosomal abnormalities might be a potential diagnostic marker for bladder cancer. Bladder wash specimens obtained from patients with and without a history of urothelial carcinoma were analyzed for centrosomal abnormalities using an immunoassay with a gamma-tubulin antibody. FISH with centromeric probes for chromosomes 4 and 9 and DNA ploidy image analysis were performed to detect aneuploidy. Defective centrosomes were found in 40 of 45 bladder wash specimens from patients with bladder cancer but in none of the 10 samples from patients without it. A large percentage (69%) of grade 1 tumors were positive for centrosomal abnormalities, and these abnormalities were increasing in numbers and size in grade 2 (93%) and grade 3 (100%) specimens. Centrosomal abnormalities and numerical chromosomal aberrations frequently appeared concomitantly in the same malignant cells. All of the specimens showing aneuploidy also exhibited centrosomal abnormalities: centrosomal defects and aneuploidy occurred together in 80% of malignant bladder tumors, with an especially high percentage in higher-grade tumors. The overall positivity of centrosomal abnormalities was higher than that of aneuploidy (88% vs. 80%), especially in grade 1 tumors (69% vs. 46%), whereas aneuploidy was strongly associated with grade 2 and grade 3 tumors. Centrosomal abnormalities are common in bladder cancer, even in low-grade tumors, and strongly associated with cancer grade and aneuploidy, especially in high-grade neoplasms. Centrosomal abnormalities appear to be intrinsic to aneuploidy and tumorigenesis and may be potential markers for early detection of bladder cancer. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12866024     DOI: 10.1002/ijc.11251

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  UXT is a novel centrosomal protein essential for cell viability.

Authors:  Huiwu Zhao; Qiang Wang; Hongtao Zhang; Qingdu Liu; Xiulian Du; Mark Richter; Mark I Greene
Journal:  Mol Biol Cell       Date:  2005-10-12       Impact factor: 4.138

2.  Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study.

Authors:  Lee E Moore; Ruth M Pfeiffer; Cristina Poscablo; Francisco X Real; Manolis Kogevinas; Debra Silverman; Reina García-Closas; Stephen Chanock; Adonina Tardón; Consol Serra; Alfredo Carrato; Mustafa Dosemeci; Montserrat García-Closas; Manel Esteller; Mario Fraga; Nathaniel Rothman; Núria Malats
Journal:  Lancet Oncol       Date:  2008-03-12       Impact factor: 41.316

Review 3.  Xeroderma Pigmentosum: A Model for Human Premature Aging.

Authors:  Elizabeth R H Rizza; John J DiGiovanna; Sikandar G Khan; Deborah Tamura; Jack D Jeskey; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2021-01-09       Impact factor: 8.551

4.  Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors.

Authors:  Javier Del Rey; Esther Prat; Immaculada Ponsa; Josep Lloreta; Antoni Gelabert; Ferran Algaba; Jordi Camps; Rosa Miró
Journal:  BMC Cancer       Date:  2010-06-11       Impact factor: 4.430

Review 5.  A clinical overview of centrosome amplification in human cancers.

Authors:  Jason Yongsheng Chan
Journal:  Int J Biol Sci       Date:  2011-10-16       Impact factor: 6.580

6.  Overexpression of active Aurora-C kinase results in cell transformation and tumour formation.

Authors:  Jabbar Khan; Frédéric Ezan; Jean-Yves Crémet; Alain Fautrel; David Gilot; Marine Lambert; Christelle Benaud; Marie-Bérengère Troadec; Claude Prigent
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

7.  DNA index determination with Automated Cellular Imaging System (ACIS) in Barrett's esophagus: comparison with CAS 200.

Authors:  Qin Huang; Chenggong Yu; Michael Klein; James Fang; Raj K Goyal
Journal:  BMC Clin Pathol       Date:  2005-08-12

8.  Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic Targets.

Authors:  A Porrello; R B Piergentili
Journal:  Curr Genomics       Date:  2016-02       Impact factor: 2.236

9.  Structural centrosome aberrations favor proliferation by abrogating microtubule-dependent tissue integrity of breast epithelial mammospheres.

Authors:  D Schnerch; E A Nigg
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

Review 10.  Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.

Authors:  Karuna Mittal; Jaspreet Kaur; Meghan Jaczko; Guanhao Wei; Michael S Toss; Emad A Rakha; Emiel Adrianus Maria Janssen; Håvard Søiland; Omer Kucuk; Michelle Dian Reid; Meenakshi V Gupta; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2020-10-26       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.